| scholarly article | Q13442814 |
| P2093 | author name string | Shawn D Hingtgen | |
| Juli Rodriguez Bagó | |||
| Kevin T Sheets | |||
| P2860 | cites work | Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells | Q45882070 |
| Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma | Q45887455 | ||
| Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. | Q46175129 | ||
| In vivo tracking of neural progenitor cell migration to glioblastomas | Q48209565 | ||
| Poor drug distribution as a possible explanation for the results of the PRECISE trial | Q48374857 | ||
| Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells | Q48515817 | ||
| The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development | Q48582810 | ||
| Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. | Q54768075 | ||
| Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy | Q70147645 | ||
| Opposite effects of early maternal deprivation on neurogenesis in male versus female rats | Q21144216 | ||
| The blood-brain barrier: bottleneck in brain drug development | Q22336985 | ||
| Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells | Q24322310 | ||
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 | ||
| Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates | Q27007519 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy | Q28176737 | ||
| Isolation and characterization of neural progenitor cells from post-mortem human cortex | Q28188656 | ||
| In vivo reprogramming of adult pancreatic exocrine cells to beta-cells | Q28292190 | ||
| CNS stem cells express a new class of intermediate filament protein | Q28577391 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Mammalian neural stem cells | Q29547657 | ||
| Taking cell-matrix adhesions to the third dimension | Q29615214 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma | Q30431291 | ||
| Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors | Q30514064 | ||
| Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse. | Q30539757 | ||
| Advances in brain tumor surgery | Q31134396 | ||
| Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury | Q33202586 | ||
| Development of a tumor-selective approach to treat metastatic cancer | Q33267284 | ||
| The role of interstitial BCNU chemotherapy in the treatment of malignant glioma | Q33954751 | ||
| New methods for direct delivery of chemotherapy for treating brain tumors. | Q34007625 | ||
| The use of neural stem cells in cancer gene therapy: predicting the path to the clinic | Q34217778 | ||
| Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 | ||
| Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 | ||
| A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy | Q34341900 | ||
| SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult | Q34394410 | ||
| Engineering toxin-resistant therapeutic stem cells to treat brain tumors | Q34444939 | ||
| Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. | Q35055059 | ||
| A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer | Q35230663 | ||
| A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma | Q35256949 | ||
| Targeting of melanoma brain metastases using engineered neural stem/progenitor cells | Q35800609 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Progenitor cell-based treatment of the pediatric myelin disorders | Q35983132 | ||
| Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects. | Q36339837 | ||
| Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. | Q36543537 | ||
| Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas | Q36695971 | ||
| Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors | Q36913828 | ||
| Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo | Q37096766 | ||
| A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration | Q37117718 | ||
| Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 | ||
| The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma | Q37124552 | ||
| Migration of human neural stem cells toward an intracranial glioma | Q37184978 | ||
| Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. | Q37202723 | ||
| Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. | Q37344283 | ||
| Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 | ||
| Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 | ||
| TRAIL on trial: preclinical advances in cancer therapy | Q37433463 | ||
| Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors | Q37447217 | ||
| Glioblastoma multiforme: a review of where we have been and where we are going | Q37530934 | ||
| FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme | Q37629395 | ||
| Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy | Q37660477 | ||
| The role of avastin in the management of recurrent glioblastoma | Q37996222 | ||
| The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates | Q38044698 | ||
| Prominin-1 (CD133): Molecular and Cellular Features Across Species. | Q38060594 | ||
| Neural stem cells: generating and regenerating the brain | Q38158714 | ||
| Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy | Q38227489 | ||
| Stem cell-based therapies for cancer treatment: separating hope from hype | Q38245163 | ||
| Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain | Q38567539 | ||
| Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. | Q38922636 | ||
| Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma | Q38972984 | ||
| Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases | Q39111100 | ||
| Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells | Q39166193 | ||
| Glioma gene therapy using induced pluripotent stem cell derived neural stem cells | Q39166287 | ||
| Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors | Q39198277 | ||
| Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. | Q39531933 | ||
| Potent tumor tropism of induced pluripotent stem cells and induced pluripotent stem cell-derived neural stem cells in the mouse intracerebral glioma model | Q39611660 | ||
| Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy | Q39644411 | ||
| A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. | Q39744489 | ||
| Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastoma | Q39746289 | ||
| Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma | Q39750216 | ||
| Chemokine CXC receptor 4--mediated glioma tumor tracking by bone marrow--derived neural progenitor/stem cells | Q39805094 | ||
| Identification of gliotropic factors that induce human stem cell migration to malignant tumor | Q39863377 | ||
| Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. | Q39898344 | ||
| Neural stem cell tropism to glioma: critical role of tumor hypoxia. | Q39906167 | ||
| Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model | Q39988659 | ||
| Neural stem cell migration toward gliomas in vitro | Q40364296 | ||
| Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | Q40394957 | ||
| Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. | Q40476541 | ||
| Human neural stem cells: electrophysiological properties of voltage-gated ion channels | Q40712044 | ||
| CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats | Q42177234 | ||
| Neural stem cells differentiated from iPS cells spontaneously regain pluripotency | Q42214600 | ||
| Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. | Q42804628 | ||
| The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma | Q42809291 | ||
| Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 | ||
| Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing | Q43578068 | ||
| Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene | Q44371834 | ||
| Gene therapy of experimental brain tumors using neural progenitor cells | Q44761775 | ||
| Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders | Q45212204 | ||
| A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. | Q45739549 | ||
| Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or typ | Q45775557 | ||
| Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. | Q45798961 | ||
| Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures | Q45857108 | ||
| P921 | main subject | neural stem cell | Q2944097 |
| P304 | page(s) | 37-43 | |
| P577 | publication date | 2015-08-24 | |
| P1433 | published in | Methods | Q6823859 |
| P1476 | title | Neural stem cell therapy for cancer | |
| P478 | volume | 99 |
| Q91711244 | A folic acid-functionalized dual-emissive nanoprobe for "double-check" luminescence imaging of cancer cells |
| Q90405817 | Cancer in a dish: progress using stem cells as a platform for cancer research |
| Q47154528 | Engineering PTEN-L for Cell-Mediated Delivery. |
| Q92604181 | High dose vs low dose irradiation of the subventricular zone in patients with glioblastoma-a systematic review and meta-analysis |
| Q64073156 | Hsa_circ_0002468 Regulates the Neuronal Differentiation of SH-SY5Y Cells by Modulating the MiR-561/E2F8 Axis |
| Q57640952 | Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection |
| Q47193869 | MicroRNA-346 regulates neural stem cell proliferation and differentiation by targeting KLF4. |
| Q51376329 | Regenerative medicine. |
| Q47142453 | Stem cells in cancer therapy: opportunities and challenges |
Search more.